Vilin Bio Med Limited

VILINBIO

INE0L4V01013

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:47:55 2024-06-21 EDT			5-day change	1st Jan Change
19.15 ^INR	-3.53%		+0.79%	-17.81%

05-29	Vilin Bio Med Limited Announces Resignation of Padmaja Kalyani Sadhanala as Director	CI
05-29	Vilin Bio Med Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Vilin Bio Med Limited Announces Resignation of Padmaja Kalyani Sadhanala as Director

May 29, 2024 at 07:36 am

Vilin Bio Med Limited announced that at the board meeting held on May 29, 2024 approved the resignation of Padmaja Kalyani Sadhanala as Director due to her to personal reasons and there are no material reasons for the resignation. Effective from May 29, 2024.

Latest news about Vilin Bio Med Limited

Vilin Bio Med Limited Announces Resignation of Padmaja Kalyani Sadhanala as Director	05-29	CI
Vilin Bio Med Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-29	CI
Vilin Bio Med Limited Announces Executive Changes	05-04	CI
Vilin Bio Med Limited Approves Resignation of Ashdeep Kaur from the Post of Company Secretary & Compliance Officer	02-24	CI
Vilin Bio Med Limited has completed an IPO in the amount of INR 120 million.	23-06-28	CI

Chart Vilin Bio Med Limited

Duration

Period

More charts

Company Profile

Vilin Bio Med Limited is an India-based company, which is engaged in the business of manufacturing and selling pharmaceutical products. The Company's primary products in manufacturing dosage forms include oral liquid (syrups/suspensions/dry powders) (beta & non-beta-lactam), tablets & capsules (beta & non-beta-lactam) and external preparations. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotics drugs, central nervous system drugs, alimentary system drugs, genitourinary tract drugs, respiratory system & anti-allergic drugs, anti-diabetic drugs, multi-vitamins, minerals & amino acids supplements, miscellaneous drugs, liquid orals and external preparations. Its cardiovascular drugs include ATORVOSTATIN + Aspirin Capsules, Dapagliflozin 10 milligrams (mg) TAB, Fluvastatin Tablets 40 mg, PRASUGREL 10 mg tablets, and Cilnidipine five mg tablets. Its external preparations include calamine lotion, and ciprofloxacin, fluocinolone acetonide and clotrimazole ointment.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
VILIN BIO MED LIMITED	-17.81%	3.2M
ELI LILLY AND COMPANY	+51.63%	796B
NOVO NORDISK A/S	+41.51%	628B
JOHNSON & JOHNSON	-5.10%	358B
MERCK & CO., INC.	+19.90%	331B
ABBVIE INC.	+9.95%	301B
ASTRAZENECA PLC	+17.66%	244B
ROCHE HOLDING AG	+3.39%	228B
NOVARTIS AG	+10.75%	214B
AMGEN INC.	+6.99%	165B